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Identical genes in the same cellular environment are sometimes expressed differently. In some cases, including the
immunoglobulin heavy chain (IgH) locus, this type of differential gene expression has been related to the absence of
a transcriptional enhancer. To gain additional information on the role of the IgH enhancer, we examined expression driven by
enhancers that were merely weakened, rather than fully deleted, using both mutations and insulators to impair enhancer
activity. For this purpose we used a LoxP/Cre system to place a reporter gene at the same genomic site of a stable cell line.
Whereas expression of the reporter gene was uniformly high in the presence of the normal, uninsulated enhancer and
undetectable in its absence, weakened enhancers yielded variegated expression of the reporter gene; i.e., the average level of
expression of the same gene differed in different clones, and expression varied significantly among cells within individual
clones. These results indicate that the weakened enhancer allows the reporter gene to exist in at least two states. Subtle
aspects of the variegation suggest that the IgH enhancer decreases the average duration (half-life) of the silent state. This
analysis has also tested the conventional wisdom that enhancer activity is independent of distance and orientation. Thus, our
analysis of mutant (truncated) forms of the IgH enhancer revealed that the 250 bp core enhancer was active in its normal
position, ,1.4 kb 39 of the promoter, but inactive ,6k b3 9, indicating that the activity of the core enhancer was distance-
dependent. A longer segment – the core enhancer plus ,1k bo f3 9 flanking material, including the 39 matrix attachment
region – was active, and the activity of this longer segment was orientation-dependent. Our data suggest that this 39 flank
includes binding sites for at least two activators.
Citation: Collins C, Azmi P, Berru M, Zhu X, Shulman MJ (2006) A Weakened Transcriptional Enhancer Yields Variegated Gene Expression. PLoS
ONE 1(1): e33. doi:10.1371/journal.pone.0000033
INTRODUCTION
Single cell assays of gene expression in metazoa have revealed that
the same gene in the same cellular environment can sometimes be
expressed in more than one way [1,2]. That is, gene expression is
only partly determined by the available transcription factors and
nucleotide sequences, and this indeterminism contributes impor-
tantly to ontogenetic differentiation. In extreme cases, viz., imprinted
genes andthe femalemammalian X chromosome,the two allelesare
differentially expressed in nearly all cells throughout the life of the
organism. Some tissue-specific genes are also monoallelically
expressed. For example, in the case of the odorant receptors, which
comprise a large family of genes, only one allele is expressed in an
individual olfactory neuron [3]. Another particularly interesting case
is the interleukin 4 (IL4) gene, which is usually expressed in activated
T cells: individual clones each express only one IL4 allele, and that
allele is expressed at a characteristic and different rate in different
clones [4]. These phenomena raise several questions: what is the
epigenetic mark that determines that two otherwise identical alleles
are differentially expressed, how is this mark inherited through
multiple cell divisions, and what feature renders a gene susceptible to
this form of differential expression?
Some evidence suggests that the occurrence of multiple states of
expression is in some way related to the action of transcriptional
enhancers (reviewed in [5]). Thus, genes that have been
manipulated to lack an enhancer can sometimes exist in at least
two states of expression for many weeks. In one such case involving
the endogenous immunoglobulin heavy chain (IgH) locus, removal
of the enhancer from the IgH locus of a B cell line creates
conditions in which the heavy chain gene can exist in different
states of expression, ranging from highly expressed to silent [6–8].
The different states are maintained through many cell divisions by
a cis-acting mechanism. Cells switch from one state to another, but
switching is sufficiently infrequent that distinct types of clones are
recognizable, and subclones generally, but not always, resemble
the parent clone. Thus, these different states are metastable, and
heavy chain expression in each clone is typically variegated.
Because the endogenous IgH locus is beset with redundant
regulatory elements, it is difficult to identify the direct effects of
deleting the enhancer. We sought therefore to generate variegated
expression with simple transgenes and then to identify molecular
requirements for variegated expression. As described here, we
measured expression not only in the presence and absence of the
IgH enhancer, but also in intermediate circumstances, using
weakened enhancers. In particular, we examined expression of
a reporter gene that was linked to an enhancer that had been
weakened either by partial deletions or by inserting a leaky
insulator. Whereas expression was uniformly high in the presence
of the enhancer and undetectable in its absence, expression driven
by the weakened enhancers was variegated. That is, in the case of
weakened enhancers, expression of the reporter gene was
maintained at different levels in different clones and varied
significantly among cells within individual clones. These results
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PLoS ONE | www.plosone.org 1 December 2006 | Issue 1 | e33lead us to conclude that genes in which expression is driven by
a weak enhancer can persist in more than one state of expression
for many cell divisions. Subtle features of this variegation suggest
that the function of the enhancer is to decrease the average
duration (half-life) of the silent state rather than to increase the
duration of the expressed state.
In the course of this analysis we have also obtained results that
activity of the IgH enhancer depends strongly on the distance and
orientation to the promoter.
RESULTS
Structure and assay of the reporter gene
In order to measure expression of reporter genes that are all in the
same genomic context, we used recombination-mediated cassette
exchange (RMCE) to construct isogenic cell lines in which a single
transfected reporter gene was inserted at a reproducible genomic
site in a hybridoma cell line. The RMCE system, which uses Cre
recombinase and the cognate LoxP sites, is illustrated in Figure 1
and is described in detail elsewhere [9]. The reporter gene and
recipient cell line are derived from the mouse hybridoma cell line,
Sp6, which secretes IgM(k) specific for the hapten trinitrophenyl.
The reporter gene is a truncated version of the Sp6 immunoglob-
ulin m heavy chain gene, and the recipient cell line, Z10/HyTK,
also derived from Sp6, lacks the endogenous m gene but still
expresses the k light chain. Transfectants of Z10/HyTK that
express the m gene therefore incorporate the m protein into IgM,
which is then secreted into the culture medium. The recipient cell
line bears a single copy of the ‘‘target’’ HyTK fusion gene, which
confers resistance to hygromycin and sensitivity to gancyclovir and
Figure 1. Structure of the reporter cassettes
a) The endogenous m gene. The boxes labeled V and C represent the exons encoding the variable (V) and constant (Cm) regions of the
immunoglobulin m heavy chain gene. The relative positions of the intronic enhancer (Em) and switch (Sm) regions in the V-C intron are shown. The Em
enhancer is depicted with three components: the core enhancer (E) flanked by matrix attachment regions, M and M9.
b) Recombination-mediated cassette exchange. The upper panel depicts a DNA segment in which (inverted) LoxP sites (1L and L1) flank a gene
encoding the HyTK fusion protein (hygromycin-resistance and thymidine kinase [gancyclovir sensitivity]). As described previously, this DNA segment
was inserted in the genome of the recipient hybridoma cell line [9]. The HyTK and m cassettes are represented as thick lines, with major exons as
rectangles, the LoxP sites as triangles (L1 in the ‘‘forward’’ orientation, 1L in the ‘‘reverse’’ orientation). The three-stranded line represents the
chromosomal DNA. The residual backbone of the vector that is shared between the target and the replacement is represented as a thin line; the
remainder of the reporter cassette is represented as a dotted line.
The middle panel depicts the structure of the replacement vector designed to substitute a modified m gene for the Hy-TK gene via Cre-mediated
recombination of the LoxP sites. This vector lacks the switch (Sm) region and was constructed by joining two segments of the m gene of the Sp6
hybridoma: The 2.0 kb V-bearing segment includes the DNA between the PacI site (,850 bp 59 of the initiator ATG) and the NgoMIV site 39 of J4. The
4.6 kb Cm-bearing segment includes the DNA between the SnaI site 59 of Cm and the SphI site 39 of Cm. DNA segments were inserted either in the
intron at the NgoMIV site (denoted i), 1.2 kb 39 of the initiator ATG, or 39 of Cm at the SphI site (denoted 39), 5.9 kb 39 of the ATG.
The lower panel depicts the structure after the m reporter cassette has replaced the HyTK gene. To distinguish replacements from random insertions
we made use of the HinDIII (H) and NheI (N) sites that distinguish the DNA that flanks the HyTK and m genes. The notations (i) and (39) indicate the
two sites where enhancer-derived segments were inserted.
c) Structure of the reporter gene used for assaying insulator segments.
d) The enhancer-derived segments. The ‘‘full’’ enhancer corresponds to the 2034 bp DNA segment bounded by the NgoMIV and Bst1107I sites, which
are denoted as nucleotides 1 and 2034, respectively. The indicated subsegments were prepared by PCR, and nucleotide positions of their endpoints,
numbered from the first nucleotide of the NgoMIV site are as follows: M, 1-782; E, 783-1035; M9, 1036-2034; p, 604-782; p9, 1036-1295; q9, 1296-1342;
r9, 1343-1654; s9, 1655-1976. The XbaI sites that are often used to delimit the MARs are at 448 and 1441. The Bright binding sites are P1, 624-648; P2,
733-767; P4 1183-1202; P4, 1237-1276.
e) Subsegments of the gpt cassette. The full gpt expression cassette includes the SV40 promoter (S), the gpt structural gene (gpt) and the SV40 polyA
site (T). The gpt structural gene was divided into three subsegments, denoted x, y z. The nucleotide positions are measured from the first nucleotide
of the SphI site in the SV40 promoter.
The figures are not to scale.
doi:10.1371/journal.pone.0000033.g001
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with the m reporter gene renders the cells gancyclovir-resistant
(gan
R). The LoxP sites (denoted L1 and 1L) are inverted with
regard to each other in order to prevent Cre-mediated excision of
the target cassette [10]. In previous work we analyzed numerous
independent replacements bearing the reporter gene in one
particular (reversed) orientation [9]. In this chromosomal site and
in this orientation expression of the reporter gene is uniform and
reproducible in the presence of the IgH enhancer, and no
expression is detectable in the absence of an enhancer. These
features suggested that this system might be suitable for identifying
conditions for variegated expression.
The endogenous m gene includes an enhancer in the second (J-
Cm) intron, and our original m reporter gene had this same
arrangement. Because altering the enhancer in this position might
alter the processing of this transcript and thus obfuscate effects on
transcription, the enhancer and insulator were placed 39 of the
transcription unit (Fig. 1). Thus, the reporter cassettes had one of
three general structures: (a) the enhancer in the J-Cm intron, (b) the
enhancer 39 of Cm and (c) an insulator inserted between Cm and
the enhancer in the 39 position.
As noted above, previous work on the endogenous IgH locus
showed that deletion of the intronic enhancer resulted in
variegated expression of the m gene [6–8]. Variegated expression
in the endogenous locus of the hybridoma cells was evident in two
ways: clonal heterogeneity (differences among clones in their
average level of expression) and cellular heterogeneity (differences
in expression among cells within a clone). In order to discern in the
simpler RMCE system whether the structure of the reporter gene
uniquely determined expression or allowed variegation, we
examined m expression by multiple independent replacements
with the same reporter gene (Table 1). As the first step, we selected
gan
R transfectants, which were then tested with a simple PCR-
based assay to identify colonies (replacements) in which the
reporter cassette had replaced the target cassette in the reversed
orientation [9]. As an initial test for variegation, the culture fluid of
each replacement was assayed for secreted IgM by ELISA, and
those replacements with the lowest (denoted /a) and highest
(denoted /b) titers were examined further to confirm that the m
reporter cassette was complete and that there were no additional
copies of the reporter either at the target site or elsewhere in the
genome. The ELISA used for this initial screening had a three-fold
reproducibility. Thereafter, expression of the reporter gene was
examined more precisely and informatively using both clonal
(ELISA, Northern blot) and single cell (flow cytometry) assays. As
presented below, in many cases there was no significant difference
between independently derived transfectants. In other cases,
independent transfectants expressed the same reporter gene
differently and were investigated further.
Activity of the enhancer in the 39 position
The intronic enhancer of the IgH locus includes a ‘‘core’’
enhancer (denoted E) that has binding sites for numerous
transcription-activating factors. The sequences flanking the core
bind to the nuclear matrix and are therefore referred to as ‘‘matrix
attachment regions’’ (MARs, denoted as M and M9 in Figure 1).
Other work showing that the core enhancer was sufficient to
stimulate expression in transfected cell lines suggested that the core
enhancer would be sufficient to stimulate expression of the m
reporter in our system. Table 1 presents the initial ELISA
measurements of secreted IgM from replacements bearing
different reporter genes. Within the experimental error (,3 fold)
of this ELISA, we detected no significant difference in m expression
among transfectants bearing the same reporter gene. As presented
in Table 1, the core enhancer stimulated m expression only when
located in its normal intronic position (#616), 1.4 kb 39 of the
promoter, and not when it was 6 kb 39 of the promoter (#630). By
contrast, the full enhancer, i.e., the core enhancer flanked by the
MARs, was active in both the intronic (#625) and 39 positions
Table 1. Position-dependent and orientation-dependent
activity of the core enhancer.
......................................................................
Cell line Structure of m gene # tested IgM ELISA
Z10/HyTK none (recipient cell) ,0.1
range
RMCE low high
transfectants -V–enhancer–Cm–
625/a MEM9 81 0
/b 20
624/a - 6 ,0.1
/b ,0.1
616/a E 4 2
/b 2
-V–Cm– enhancer
626/a MEM9 71 5
/b 30
630/a E 4 ,0.1
/b ,0.1
637/a pEp9 3 ,0.1
/b ,0.1
639/a MEp9 3 ,0.1
/b ,0.1
640/a pEM9 46
/b 25
642/a EM9 25
/b 11
643/a M9 4 ,0.1
/b ,0.1
653/a Ep9 4 ,0.1
/b 0.3
655/a M9E 2 0.1
/b 0.1
The reporter genes have the general structure depicted in Figure 1, with an
enhancer bearing the indicated portions of the core enhancer or flanking
segments inserted in the intronic or 39 position. The recipient cell line, Z10/
HyTK, was co-transfected with the Cre expression vector and a vector bearing
the indicated reporter gene. To obtain independent transfectants, the
transfected cells were divided into six flasks, and gan
R cells were selected. Gan
R
cells were then plated at limiting dilution, and the resulting colonies were
screened as follows [9]. The DNA of gancyclovir-resistant transfectants was
tested to assess whether a replacement had occurred, and the culture fluid of
each replacement was titered for secreted IgM. The DNA of the colonies
yielding the lowest (denoted ‘‘a’’) and highest (denoted ‘‘b’’) titers was analyzed
to ensure that each transfectant contained only a single, intact copy of the m
reporter gene. (If this condition was not met, then the next highest or lowest
was examined.) The ‘‘range’’ indicates the highest and lowest IgM titers that
were measured for each reporter; ‘‘# tested’’ is the number of replacements
that were titered for IgM less the number that were found to have an incorrect
DNA structure. The ELISA titer was measured in arbitrary units. The
reproducibility of the ELISA was approximately three fold, so differences of
greater between lowest and highest were taken as preliminary evidence of
variegation.
doi:10.1371/journal.pone.0000033.t001
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PLoS ONE | www.plosone.org 3 December 2006 | Issue 1 | e33(#626). We conclude that the activity of the core enhancer is
strongly distance-dependent.
The foregoing finding suggested that the core enhancer was
strengthened by an element (s) in the adjoining M or M9 segments.
The segments denoted p and p9 each include two binding sites for
a transcriptional activator, Bright [11], and we considered that
these sites might account for difference in activity between the core
and full enhancers. We therefore constructed truncated versions of
MEM9 that included or lacked p or p9 and tested by ELISA for
secreted IgM whether they stimulated expression (Table 1). These
results indicated that most or all of the activity that differentiated
MEM9 from E was included in M9 and that p9 was not sufficient.
As expected from earlier analyses of the M and M9 segments [12],
M9 alone was inactive.
It is commonly stated that the activity of enhancers is
independent of orientation. In the light of the distance dependence
of the core enhancer, we also tested the effect of inverting the EM9
segment. As indicated in Table 1, in the inverted orientation, M9E
(#655) was inactive. These findings, which suggest that the activity
of these forms of the enhancer is strongly sensitive to both distance
and orientation, are considered further in the Discussion.
In order to assess m expression more directly and accurately, we
measured m RNA levels by Northern blot (Fig. 2). These
measurements confirmed that the core enhancer was active in
the intron but not in the 39 position, and that most of the activity
associated with MEM9 was conferred by the M9 segment.
The ELISA measurements of secreted IgM from independent
replacements did not reveal evidence of clonal heterogeneity. i.e.,
independent transfectants expressing the same reporter gene
secreted the same amount of IgM, within the experimental error
of the IgM ELISA. To test for cellular heterogeneity, we used flow
cytometry with fluorescent m-specific antibody to measure the
amount of m protein in individual cells. The m protein is secreted as
IgM, so intracellular m is closely related to the contemporaneous
amount of m mRNA. To quantify and compare the level of
reporter gene expression we calculated a normalized mean
fluorescence, N, in which mean fluorescence of different reporters
was normalized to the mean fluorescence of a reporter with the full
enhancer. To quantify heterogeneity, we calculated a corrected
coefficient of variation, C, in which variation that was unrelated to
reporter gene expression was discounted (see legend to Figure 3).
These results generally indicated that expression of reporters
bearing the EM9 segment, e.g., #626 and #642, was homoge-
neous, i.e., the value of C for these reporters was similar to that of
the parental hybridoma. In the case of reporter bearing the
segment pEp9 (#640), expression in replacement #640/a was
reproducibly more heterogeneous than in #640/b, but we
considered this effect too small to allow further analysis.
Expression using an insulated enhancer
Analyses of imprinted genes have suggested that transcriptional
insulators can exist in two states: either inactive (methylated) or
active (unmethylated); the state in turn determines whether a distal
enhancer can or cannot stimulate expression of a linked pro-
moter[13,14]. Non-physiological DNA segments can also function
as insulators. In particular, our previous work on targeted
recombinants of the endogenous IgH locus suggested that the gpt
expression cassette that was used as a selectable marker includes
segment with insulator activity [15]. We considered therefore that
the gpt cassette might also assume two states and thus cause the
variegated expression of the m gene that we had previously
observed in the targeted endogenous IgH locus. We confirmed
using standard assays that the gpt cassette could act as an insulator
(see Figure S1). We then constructed several replacement vectors
in which segments bearing the full or truncated gpt cassettes were
inserted 59 of the enhancer in the reporter cassette (Fig. 1d) and
examined their mode of expression.
In the case of reporters bearing the complete gpt cassette, m
expression was undetectable in all eight independent replace-
ments, indicating that the gpt cassette reduced expression by at
least 80 fold, consistent with the results in the Appendix. We then
sought to examine expression with a less stringent insulator and
tested segments of the gpt cassette (Fig. 1e). Of particular interest,
a segment that was wholly derived from the bacterial gene yielded
variegated expression. Thus, independent transfectants, #635/
a and #635/b, which bore the ‘‘yz’’ segment of the gpt structural
gene, yielded heterogeneous populations that expressed the m gene
at different levels, as measured by ELISA (Table 2) and by flow
cytometry (Fig. 4a). Moreover, cellular heterogeneity, as measured
by the corrected coefficient of variation, C, was several fold greater
for the insulated reporters than for the uninsulated enhancer
(Fig. 4a). As considered further in the Discussion, cellular
heterogeneity might provide insight into the role of the enhancer.
In the case of #635, we tested whether the distinctive level of
expression was a heritable (stable) feature of these cell lines by
subcloning #635/a and #635/b and measuring the level of
secreted IgM by ELISA for each subclone (Fig. 4b). Each set of
Figure 2. Analysis of m expression by northern blot
a) As described in the text, multiple independent replacements were
isolated for each vector, and the concentration of IgM in culture
supernatant of these cell lines was measured by ELISA (Table 1). Total
RNA was isolated from representative cell lines and analyzed by
Northern blot probed with segments of the m and k genes. The
intensity of the bands was quantified by phosphorimager, and the m/k
ratio, normalized to the value for cells expressing #626, is indicated
below each lane.
b) Results from the northern blot in (a) are listed next to a diagram of
each enhancer-derived segment.
doi:10.1371/journal.pone.0000033.g002
Variegated Gene Expression
PLoS ONE | www.plosone.org 4 December 2006 | Issue 1 | e33re-subclones resembled their parent more closely than they
resembled their non-parent, thus indicating that the higher and
lower expression phenotypes were sufficiently stable to be
inherited in most re-subclones. Similar results were obtained for
#629, which included the SV40 promoter and the ‘‘xy’’ segment
of the bacterial gpt gene (data not shown).
Expression using a mutant enhancer
The gpt-derived segments that yielded variegated expression were,
of course, non-physiological. Nevertheless, these results raised the
question whether the variegated expression resulted from the
presence of the gpt-derived insulator or from the weakened
enhancer. Our finding that the core enhancer was strengthened by
the adjoining M9 DNA suggested that some intermediate structure
between EM9 and E might serve as a weakened enhancer. We
therefore tested whether shortened versions of the M9 segment
were active when adjoined to E (Table 3). For this purpose, the M9
segment was divided into four subregions, denoted p9q9r9s9 (Fig. 1),
and truncated versions of M9 bearing different subregions were
tested for activity. Each of the truncations eliminated most or all of
the activity. For those truncations that allowed low but detectable
expression of the m gene, , e.g., enhancer segments Ep9q9r9 (#651)
and E-q9r9s9 (#654), the gene structure did not uniquely
determine the level of m expression. Thus, colonies #654/a and
#654/b differed in m expression by six fold, both as measured with
the ELISA for secreted IgM (Table 2), and as measured with flow
cytometry of intracellular m chain (Fig. 5). Similarly, #651/a and
#651/b differed in m expression by six fold in the ELISA and by
four fold in average fluorescence. Moreover, the population of
#651a was biphasic, and this colony yielded subclones, exempli-
fied by #651/b3 and #651/b5, which differed in m expression by
,15 fold. To test whether lower and higher expression were
heritable features, these two subclones were re-subcloned, and
Figure 3. Flow cytometry of m expression from reporter gene bearing different segments of the full enhancer.
Transfectants bearing the indicated reporter genes were analyzed by flow cytometry. Cells were fixed and permeabilized, and intracellular m chains
were stained with m-specific fluorescent antibodies. ,10
4 cells were then analyzed. In these histograms the horizontal axis indicates the mean
fluorescence (logarithmic scale) and the vertical axis the number of cells with the corresponding fluorescence. M is the mean fluorescence for each
population. Z10/HyTK, the recipient cell line was used in this case as the negative control, and its mean ‘‘fluorescence’’, M0, for each experiment was
subtracted from the mean fluorescence, Mx, measured for a cell population expressing reporter ‘‘x’’. This corrected fluorescence is compared with
M626, the corrected fluorescence in that experiment for the reporter #626 with the full enhancer. Thus, the ‘‘normalized’’ fluorescence, Nx, for reporter
‘‘x’’ was calculated as Nx =( M x2M0)/(M6262M0), where M626 is the mean fluorescence for the reporter with the full enhancer and M0 is the
fluorescence for the recipient cell line or other m non-expresser. s is the standard deviation of the fluorescence. In order to correct for variation in
background ‘‘fluorescence’’, we calculated a corrected coefficient of variation, Cx, for reporter ‘‘x’’ as Cx =( sx
22s0
2)
1/2/Mx2M0, where sx and s0 are
the standard deviations associated, respectively, with reporter ‘‘x’’ and with the recipient cell line or other m non-expresser.
doi:10.1371/journal.pone.0000033.g003
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fluorescence as a measure of m expression, each set of re-subclones
resembled their parent more closely than they resembled their
non-parent, thus indicating that the higher and lower expression
phenotypes were sufficiently stable to be inherited in most re-
subclones. Flow cytometry indicated further that m expression
from these truncated enhancers was also associated with increased
cellular heterogeneity, i.e., the corrected coefficient of variation
was much larger for the mutant than for the unimpaired enhancer.
In summary, reporter genes that were linked to weakened
enhancers yielded variegated expression, both in the sense that
independent clones often differed in their average level of m
expression, and in the sense that m expression was heterogeneous
among the cells within a single clone.
Effect of 3-aminobenzamide
In some, if not all, cases the activity of mammalian insulators
depends on the protein CTCF. CTCF is a substrate for
polyadenylribosylpolymerase (PARP), and treatment of cells with
3-aminobenzamide (3AB), an inhibitor of PARP, increased
expression of many CTCF-associated genes [16]. These results
suggested that the activity of many insulators might require
polyadenylribosylation of CTCF. These considerations suggested
that treatment with 3AB might both increase expression and
reduce variegation for reporter genes with an insulated enhancer.
However, other proteins in chromatin are also substrates for
PARP, and an alternative explanation for the 3AB effect was that
gene expression is dampened by another (unspecified) PARP-
dependent substrate in chromatin. This possibility suggested that
3AB might increase expression and reduce variegation both for
reporters with an insulated enhancer and reporters with a mutant
enhancer. To test these possibilities, we examined the effects of
3AB on both types of reporters. For comparison we also assayed
reporters bearing previously tested insulators, the DMD segments
of the mouse (#648) and human (#650) igf2/H19 locus. The
activity of these segments was assayed by Northern blot (Fig. 6),
flow cytometry (Fig. 7), and ELISA (no shown). For most reporter
genes – both those bearing the gpt-derived insulator, and the igf2/
H19 insulators, as well as those bearing the mutant enhancers –
3AB caused significant (usually ,3 fold) increases in expression.
Flow cytometry indicated that 3AB did not reduce the heteroge-
neity and even increased heterogeneity greatly in some cases, viz.,
enhancer segment Ep9q9r9 (#652) and the partially insulated
enhancer of #635 (Fig. 6). After transfer of the cells back to
normal medium, the changes induced by 3AB were reversed (data
not shown). The significance of our finding that 3AB increased
expression of both insulated and mutant enhancers is considered
further in the Discussion.
DISCUSSION
Our results provide information on several topics:
a) Role of the 39 matrix attachment region;
b) Distance and orientation dependence of an enhancer.
Table 2. Expression from an enhancer weakened with an
insulator.
......................................................................
Cell line Structure of m gene # tested IgM ELISA
Z10-HyTK none (recipient cell) ,0.1
RMCE -V–Cm-insulator-MEM9
Transfectants
626/a none 15
Range
low high
613/a S.xyz.T 8 ,0.1
/b ,0.1
629/a S.xy 3 ,0.1
/b 2.0
635/a yz 4 0.1
/b 1.0
644/a y 2 15
/b 15
The reporter genes bore segments of the gpt expression cassette, inserted
between the full (MEM9) enhancer and the promoter of the m gene, as depicted
in Figure 1. As defined in Figure 1, S denotes the SV40 promoter, xyz are
segments of the gpt structural gene, and T is the SV40 poly A addition segment.
Transfectants bearing the indicated reporter genes were isolated and analyzed
as described in Table 1.
doi:10.1371/journal.pone.0000033.t002
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Figure 4. Flow cytometry of m expression from partially insulated
reporter gene.
(a) Two independent transfectants expressing reporter #635 (#635/
a and #635/b) were analyzed by flow cytometry, as described in
Figure 3.
(b) The transfectants #635/a and #635/b were subcloned, and secreted
IgM was measured for each subclone.
The statistical parameters, M, N, s, and C are defined in the legend to
Figure 3.
doi:10.1371/journal.pone.0000033.g004
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d) Requirements for variegated gene expression.
e) Function of the enhancer.
Role of the 39 MAR
The function of the matrix attachment regions (MARs) that flank
the core enhancer has been elusive. As assayed in transgenic mice,
the full enhancer, MEM9, stimulates transcription only in
lymphoid cells [17]. Analysis of tissue specificity using transfected
cell lines indicated that the core enhancer alone stimulates
expression in non-lymphoid cells, but that flanking segments that
include the MARs inhibit expression in non-lymphoid cells and in
this way render the enhancer activity lymphoid-specific [18–20].
In the context of models in which MARs isolate functional
chromosomal domains, these results suggested that in non-
lymphoid cells the MARs might prevent the enhancer from
interacting with the promoter.
The importance of the MARs differs strikingly in transfected cell
lines and transgenic mice. As noted above, MARs are not required
for high level expression of an immunoglobulin gene that has been
transfected into B-cell lines. By contrast, MARs are required for
transgene expression in (Abelson) B-cell lines that are made from
transgenic mice [12]. It was suggested that the requirement for the
MARs in transgenic mice might arise because the transgene
becomes methylated in early development, and, in fact, if vector
DNA is methylated prior to transfecting the cell line, MARs are
required for enhancer-stimulated expression [21]. Further work
showed that MARs extend the region of accessible DNA, i.e.,
DNA that was inaccessible when 1 kb from the core enhancer was
accessible when the enhancer was adjoined by the MARs [12,22].
The difference between transfected cell lines and cell lines
derived from transgenic mice suggested that the MARs function
only to establish an active locus. However, an ongoing role for the
MARs is implied by the discovery of two proteins, Bright and
SatB2, that stimulate expression in transfected cell lines, if the
reporter gene is linked to the full enhancer (MEM9) but not when
it is linked to only the core enhancer [11,23].
The foregoing analyses in which the MARs stimulated various
reporter genes, either in cell lines or in transgenic mice, also
contrast with the observation that deleting the intronic MARs
from the endogenous IgH locus of ES cells did not affect IgH
expression in B-cells [24]. However, this difference between
expression of IgH-derived transgenes and the modified IgH locus
might simply reflect the contribution of other MARs in the
endogenous locus that were absent in the transgenes.
In the present work, we found that the core enhancer, which
was active in its normal intronic position, ,1.4 kb 39 of the
promoter, was inactive when placed ,6k b3 9 of the promoter.
Table 3. Expression from an enhancer weakened by mutation.
......................................................................
Cell line Structure of m gene # tested IgM ELISA
Z10-HyTK none (recipient cell) ,0.1
RMCE
transfectants -V–Cm–enhancer
626/a MEM9 (=MEp9q9r9s9)1 5
range
low high
637/a pEp9 3 ,0.1
/b ,0.1
653/a Ep9 4 ,0.1
/b ,0.1
651/a Ep9q9r9 40 . 1
/b 0.6
652/a Ep9r9s9 30 . 3
/b 3.0
654/a E-q9r9s9 20 . 2
/b 1.0
The reporter genes bore the core enhancer plus segments of 39 MAR (M9). The
segments of the 39 MAR, p9q9r9s9, are defined in Figure 1. Transfectants bearing
the indicated reporter genes were isolated and analyzed as described in Table 1.
doi:10.1371/journal.pone.0000033.t003
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Figure 5. Flow cytometry of m expression from reporters with mutant
enhancers.
a) Two independent transfectants expressing the #654 reporter were
analyzed by flow cytometry.
b) As in (a) two independent transfectants bearing reporter #651 were
analyzed by flow cytometry, as described in Figure 3. The transfectant
651/b was biphasic and yielded subclones with different levels of
expression, 651/b3 and 651/b5. To assess the stability of this difference,
these subclones were re-subcloned, and the mean fluorescence, M, and
normalized fluorescence, N, of eight re-subclones were measured. Nm,
the mean value for N for the re-subclones and the associated standard
deviation, were calculated. The values of Nm for each set of subclones
were significantly different and close to the value of the N for their
respective parents.
The statistical parameters, M, N, s, and C are defined in the legend to
Figure 3.
doi:10.1371/journal.pone.0000033.g005
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attachment region (MAR), this compound element, EM9, was
active in both positions. These results resemble the finding noted
above that the MARs extended the region of DNA that is rendered
accessible by the core enhancer. That is, the results from both
experimental systems suggest that the MARs increase the effective
range of the core enhancer. However, the scale is different in the
two experimental systems: in the present system the core enhancer
stimulated expression from a promoter that was 1.4 kb distal; in
the accessibility analysis, DNA that was only 1 kb distal from the
core enhancer remained inaccessible. It might be important that
the accessibility analysis used cell lines derived from transgenic
mice, where the DNA passed through the germ line and was
subject to dense methylation. Taken together, these results thus
suggest that the core enhancer can be blocked either by a short
segment of densely methylated DNA or by a longer, relatively
unmethylated segment, i.e., the activity of the core enhancer is
distance-dependent. Additional work might be able to establish
whether the MARs render the enhancer independent or less
dependent on distance.
Our analysis suggests that the M9 segment includes at least two
protein binding sites, in that both the 260 bp segment denoted p9
and the 680 bp segment, q9r9s9, are required for the activity
provided by M9. Two proteins – Bright and SatB2 – have been
identified that stimulate expression from reporter genes that are
linked to the MARs of the IgH locus [11,23]. The binding sites for
Bright lie within the segment Ep9 (#653), which was inactive, thus
arguing that the potentiator requires another factor in addition to
Bright for activity, perhaps SatB2.
In the analyses of Bright and SatB2, MAR DNA stimulated
expression only when the reporter was cotransfected with an
expression vector for either Bright of SatB2 [11,23]. This
requirement did not apply in our system, perhaps because the
hybridoma cell line that we used had higher levels of Bright and/
or SatB2 than did the cell lines used in the cotransfection
experiments.
Orientation dependence of the enhancer
It has often been reported that that enhancers function in both
orientations. Three quite different reasons might account for such
findings: (1) true orientation-independence (enhancers might actually
function in a way that is intrinsically independent of orientation);
(2) symmetric structure (enhancers might often contain two symmet-
rically arranged functional units, i.e., orientation independence is
a consequence of the built-in redundancy of these enhancers but
not of their basic function); (3) deficient experimental design
(reporter genes are usually assayed on a circular DNA molecule or
in a tandem array of vectors lying in both orientations, and these
circumstances present the enhancer, inadvertently, but nonetheless
effectively, in both relative orientations. In our LoxP/Cre system,
only a single reporter gene was assayed and the orientation of the
enhancer was unambiguous. Our finding that the inverted
segment, denoted M9E, in #655, was inactive indicates that the
activity of this enhancer, EM9, was orientation-dependent. More
work will be needed to establish which component – E , M9 or
both – is orientation-dependent and whether the longer segments
that were assayed in earlier analyses are constructed with
symmetric units.
Inhibition of reporter gene expression by the gpt
cassette
Numerous publications have documented that the selectable
markers commonly used to enrich for targeted recombinants
sometimes depress the expression of neighboring genes. In
particular, our previous work on targeted recombinants of the
endogenous IgH locus suggested that the gpt cassette is an insulator
Figure 6. Analysis of m RNA produced by weakened enhancers.
a) Total RNA was isolated from the indicated cells and analyzed by
northern blot as described in Figure 2. The asterisk indicates that the
cells were incubated for approximately five days with 6.7 mM 3-
aminobenzamide prior to isolating RNA. The upper panels present
results for various insulators derived from the gpt cassette and from the
igf2/H19 locus; the lower panels present results for various mutant
enhancers. For vectors #629 and $635, the segments of the gpt
cassette, S, x, y, z are defined in Figure 1. Reporters #648 and #650
bear the insulator (DMD) from the igf2/H19 loci of mouse and human,
respectively.
b) The normalized m/k ratios from (a) for cells grown in normal medium
(NM) or medium supplemented with 3-aminobenzamide (AB) are listed
next to diagrams showing the insulators and enhancers in the reporter
genes.
doi:10.1371/journal.pone.0000033.g006
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the bacterial gpt structural gene was inhibitory, i.e., expression of
the m reporter (and the neo gene, Appendix) was depressed in the
absence of any SV40-derived regulatory sequence. However, the
full gpt cassette inhibited more strongly than just the structural
gene, and perhaps the SV40 promoter competes for a partially
insulated enhancer. A 2.3 kb segment derived from phage l was
inactive (Appendix), thus arguing that prokaryote-derived DNA is
not generally inhibitory.
Requirements for variegated expression
When the reporter gene was under the control of a partially
inactivated or partially insulated enhancer, expression of the m
gene was variegated. By contrast, when the reporter gene was
linked to an uninsulated, EM9-containing segment (MEM9, PEM9,
or EM9), the reporter gene in each of 13 independent cell lines was
expressed at a similar high level, and in each case the population of
cells was generally homogeneous. We also examined m expression
in 14 independent cell lines in which the reporter genes lacked the
q9r9s9 segment (MEP9, PEP9,E P 9), and found that these cell lines
uniformly failed to express the m gene at a detectable level. We
conclude that variegated expression requires a weakened, but non-
zero, enhancer.
Variegated expression in our system had two notable features: (i)
clonal heterogeneity, i.e., the mean level of m expression was
different in different clones, and (ii) cellular heterogeneity, i.e.,
expression of the m reporter was heterogeneous within a clonal
population of cells. Clonal heterogeneity implies that expression
can persist in different states through multiple cell divisions. In the
Figure 7. Flow cytometry of cells treated with 3-aminobenzamide.
The indicated cells, grown either in normal medium or in medium supplemented with 3-aminobenzamide, were analyzed for intracellular m protein
by flow cytometry, as described in Figure 3. Because 3-aminobenzamide also affected the fluorescence of the m-negative cells, Z10/HyTK, the
normalized fluorescence (N or N9) for cells grown in 3-aminobenzamide was calculated two ways: For cells bearing the reporter gene, N was
calculated by subtracting the mean fluorescence of the parental cell line, Z10/HyTK, grown in normal medium; N9 was calculated by subtracting the
mean fluorescence for cells grown in 3-aminobenzamide.
doi:10.1371/journal.pone.0000033.g007
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expression was a sufficiently stable property to be inherited by
most subclones, but sufficiently unstable that subclones with
different average levels of expression were sometimes identified by
screening ,10 subclones.
The variegation seen here resembles the case of targeted
recombinants of the endogenous IgH locus, where deletion of the
intronic enhancer creates conditions in which the m gene can
persist in very different states of expression that are maintained by
a (still undefined) cis-acting mechanism [6–8]. There are also
several differences between variegation in the endogenous and
reporter genes. In the endogenous locus, variegated expression
ranged from undetectable up to the level for a full enhancer,
whereas variegated expression of the reporter gene reached only
a fraction of the full level. Also, m expression in the endogenous
locus was variegated in the presence of the full gpt cassette, while in
the present system, the full gpt cassette rendered expression
undetectable. These differences between the reporter and
endogenous genes might merely reflect the fact that these two
genes are in different genomic contexts, linked to different
regulatory elements that yield different degrees of variegation.
Alternatively, simply screening more clones might have revealed
a greater range of reporter expression. However, it might also be
important that the endogenous locus, unlike the reporter gene, was
expressed at a high level prior to removing the enhancer, i.e., in
some way prior high level expression modifies the locus and allows
wider ranging variegation.
Why was variegated expression seen only for weakened
enhancers? Previous work with a regulatable enhancer revealed
that continued, high level expression of an (initially) enhancer-
dependent gene can sometimes render expression enhancer-
independent [25]. Such a result suggests that the active and
inactive states of expression are each autocatalytic: that expression
above a specific threshold increases the likelihood that the locus
will remain active, while expression below that threshold decreases
the likelihood of activity. The importance of weakening the
enhancer might be to set expression near the putative threshold.
Effects of inhibiting PARP
In the case of the imprinted igf2/H19 locus, the different states of
the imprinted genes are thought to correspond to different states of
the insulator, which in turn are thought to correspond to different
patterns of cytidine methylation that allow or disallow binding of
the insulator-mediating protein CTCF [13,14]. This view is
further supported by the finding that CTCF is a substrate for
PARP, and that inhibition of PARP with 3AB induced expression
of the insulated allele [16]. These findings suggested that
variegation in the IgH locus might also reflect different states of
an insulator. However, this explanation does not account for
variegated expression that we found with the mutated enhancers,
as these reporter genes did not include an insulator. Nor does it
account for our finding that 3AB increased expression from
reporters with the mutant enhancers. Rather, these observations
suggest the unitary hypothesis that a weak enhancer allows
expression to occur at multiple distinct levels, that the role of an
insulator is to weaken the enhancer, and that weak expression per se
can be increased by 3AB, e.g., by the effects of blocking
polyadenylribosylation of other components of chromatin [26].
These considerations raise the question whether other methods of
weakening expression, such as reducing the strength of the
promoter or reducing the concentration of specific transcription
factors would likewise allow different states of expression that can
be transmitted to progeny cells.
Function of the enhancer
As measured by the corrected coefficient of variation, weakened
enhancers yielded colonies in which expression across the
population of cells was more heterogeneous than in the case of
the full enhancer. What might be the explanation for this
increased cellular heterogeneity? Inasmuch as cells switch from
one state to another, clonal heterogeneity must contribute to
cellular heterogeneity. However, switching per se seems too slow to
account fully for cellular heterogeneity. We have considered two
additional sources of cellular heterogeneity in m expression. One
source is the variation expected simply because the mean number
of RNA molecules per cell was small. However, as calculated in
Methods, we estimate that there were on average 20 m RNA
molecules per cell in the variegated clones such as #651 and #654
that produced ,2% as much m RNA as #626. The coefficient of
variation for a Poisson distribution with a mean of 20 molecules is
,20%, thus less than 50% and 150% that were found for #651
and #654, respectively (Fig. 5). These calculations therefore argue
that the cellular heterogeneity in the variegating clones exceeded
the variation expected for a Poisson distribution.
We have also considered an explanation for cellular heteroge-
neity based on how an enhancer might function. Several different
lines of investigation argue that an enhancer is needed continually
[27,28], that it remains close to the promoter [29–31], and that it
facilitates delivery of RNA polymerase to the promoter [32].
Other analyses of the effects of ablating enhancers have suggested
a different model in which (a) the locus can exist in either an
expressed or silent state, (b) the rate of transcription is determined
by the promoter or other non-enhancer elements, and (c) an
enhancer serves to increase the average duration of the expressed
state and/or to decrease the average duration of the silent state
(reviewed in [5]). This model might account for cellular
heterogeneity, if the duration of the silent or expressed state is
itself a stochastic feature, akin to a half-life. To illustrate, we
consider first the case in which the half-lives of both the expressed
and silent states are short, i.e., much less than the cell division
time: in this case, cells will typically undergo many expressed and
silent periods. Because almost all cells will have gone through many
expressed and silent periods, m mRNA content will be relatively
homogeneous in the population. However, if the half-life of either
the expressed or silent state approaches cell division time then cells
will typically differ greatly in m mRNA content. In the context of
this model, our finding that cellular heterogeneity is less for cells
expressing more m mRNA suggests that a major effect of the IgH
enhancer is to decrease the half-life of the silent state. That is, by
shortening the half-life of the silent state an enhancer increases the
average m mRNA content, and by shortening the half-life of the
silent state an enhancer increases the number of silent and
expressed periods and thereby decreases the cellular heterogeneity.
Thus, the effect of the enhancer on a single parameter of
transcription – the half-life of the silent state – can account for
both cellular and clonal heterogeneity.
Significance
Here we have shown that linking a weakened enhancer to
a reporter gene allowed the reporter gene to exist in more than
one state of expression. Moreover, that state was persistent, i.e.,
the particular state was usually transmitted to progeny cells,
implying that some form of differentiation had occurred. Although
we have related variegation only to cis-acting elements – mutations
and insulators – our observations suggest that other mechanisms
that provide weak enhancer activity, such as limiting the available
enhancer-binding proteins, might also result in variegated
Variegated Gene Expression
PLoS ONE | www.plosone.org 10 December 2006 | Issue 1 | e33expression. Variegated expression in general, and monoallelic
expression in particular, might require that that activation of
expression be a low probability event. It seems reasonable that
a weak enhancer or limited access to transcription factors could be
a mechanism for activating at low probability. The present case of
expression from a weakened enhancer closely resembles the
behavior of the IL4 gene, in which many different levels of
expression are possible [4]. This similarity suggests that provision of
weak enhancer activity might also be a normal mechanism for
generating differentiated populations in the course of development.
MATERIALS AND METHODS
Vectors and DNA segments
The Cre expression vector and LoxP vector were obtained from E.
Bouhassira[10]. The structures of the replacement vectors are
described in the text and in Figure 1; the nucleotide sequences of
the replacement and target vectors are given in the additional files
of [9].
The DMD insulator segment used in the RMCE vector was
derived by PCR from the mouse igf2/H19 DMD (differentially
methylated domain) and corresponded to nucleotides 1540-3173
of the Genbank sequence MMU19619 [59-TGGACTCGGAC-
TCCC-//-GGGTCCGCTGTGACA-39].
Recombination-mediated cassette exchange
We have previously described the construction of the recipient cell
line, Z10/HyTK, transfection, selection of gancyclovir-resistant
cells, and the methods for identifying transfectants in which
a complete and intact reporter cassette has replaced the target
cassette in one particular orientation[9].
The original names of transfectants were simplified for ease of
presentation: 613/1.19.1=a, /4.7.3=b; 616/A1.6.5=a,
/A2.14.5=b; 624//C2.10.1=a, B.10.1=b; 625/ C1.7.1=a,
/A1.3.1=b; 626/B1.1.1=a, /B2.16.1=b; 629/1.9.1=a,
/A1.6.1=b; 630/2.2.1=a, /A2.4.2=b; 635/C2.23=a,
/A1.2.2=b; 637/B2.4.2=a, /A1.2.1=b; 639/A2.15.1=a,
/B1.9.1=b; 640/C.5.2=a, /E2.12.1=b; 642/20.88=a,
/10.55=b; 643/A1.1.1=a, /C1.14.1=b; 644/B1.4.1=a,
/C12.1=b; 651/A122.7=a, /A183.8=b; 652/B1.22.4=a,
/A1.9.3=b; 653/A1.12.1=a, /A2.2.1=b; 654/C2.5.1=a,
/3.2.1=b; 655/2.13.2=a, /1A.15.1=b
Analysis of m expression
ELISA’s and Northern blots were done by standard methods.
Flow cytometry of intracellular IgM has been described [6].
Cell culture
The materials for cell culture have been described [33]. As
indicated in the text, cells were treated with 6.7 mM 3-
aminobenzamide for approximately seven days prior to analysis
of m RNA and protein.
Calculation of m RNA/cell
Other analyses have estimated that large cells, such as our
polyploid hybridoma cells, contain approximately 400 pg protein
and 30 pg RNA per cell, and that mRNA constitutes 3% of the
total, or ,1 pg/cell [34–36]. Assuming that the typical mRNA is
,2 kb, 1 pg mRNA/cell corresponds to 10
6 molecules/cell. Our
ELISA measurements indicated that a culture of the Sp6
hybridoma, initiated at a concentration of 3610
5 cells/ml and
growing with a doubling time of ,16 hr, secreted 3.5 mg/ml IgM
(2.5 mg/ml m chain (,576 amino acids long)) and produ-
ced,4.5610
5 cells/ml in ,20 hr. These cells therefore made
400 pg protein/cell 6 4.5610
5 cells/ml = 180 mg/ml total
protein/ml. The m chain thus corresponds to 2.5/180 = ,1.5%
of the total protein. Assuming that mRNA length is proportional
to protein length, and that the average protein is ,450 amino
acids long, the number of m mRNA molecules in Sp6 would be 10
6
6 (0.015) 6 450/576 = ,1610
4. The cells expressing reporter
#626 contained ,11% as much m RNA as Sp6, implying that
these cells each contained on average ,1100 molecules of m RNA.
SUPPORTING INFORMATION
Figure S1 Insulator activity of gpt
Found at: doi:10.1371/journal.pone.0000033.s001 (0.65 MB PDF)
ACKNOWLEDGMENTS
We thank A. Martin, P. Sadowski, and D. Ronai for critical reading of the
manuscript.
Author Contributions
Conceived and designed the experiments: MS PA. Performed the
experiments: CC MB XZ. Analyzed the data: MS CC PA. Wrote the
paper: MS
REFERENCES
1. Hume DA (2000) Probability in transcriptional regulation and its implications for
leukocyte differentiation and inducible gene expression. Blood 96: 2323–2328.
2. Kurakin A (2005) Self-organization vs Watchmaker: stochastic gene expression
and cell differentiation. Dev Genes Evol 215: 46–52.
3. Serizawa S, Miyamichi K, Sakano H (2005) One neuron-one receptor rule in
the mouse olfactory system. Trends Genet 20: 648–653.
4. Guo L, Hu-Li J, Paul W (2005) Probabilistic regulation in TH2 cells accounts for
monoallelic expression of IL-4 and IL-13. Immunity 23: 89–99.
5. Martin DIK, Whitelaw E (1996) The vagaries of variegating transgenes.
BioEssays 18: 919–923.
6. Ronai D, Berru M, Shulman MJ (1999) Variegated expression of the
endogenous immunoglobulin heavy-chain gene in the absence of the intronic
locus control region. Mol Cell Biol 19: 7031–40.
7. Ronai D, Berru M, Shulman MJ (2002) Positive and negative transcriptional
states of a variegating immunoglobulin heavy chain (IgH) locus are maintained
by a cis-acting epigenetic mechanism. J Immunol 169: 6919–27.
8. Ronai D, Berru M, Shulman MJ (2004) The epigenetic stability of the locus
control region-deficient IgH locus in mouse hybridoma cells is a clonally varying,
heritable feature. Genetics 167: 411–21.
9. Cheng E, Collins C, Berru M, Shulman M (2005) A system for precise analysis of
transcription-regulating elements of immunoglobulin genes. BMC Biotechnol 5:
27–34.
10. Feng YQ, Seibler J, Alami R, Eisen A, Westerman KA, et al. (1999) Site-specific
chromosomal integration in mammalian cells: highly efficient CRE recombi-
nase-mediated cassette exchange. J Mol Biol 292: 779–85.
11. Herrscher RF, Kaplan MH, Lelsz DL, Das C, Scheuermann R, et al. (1995) The
immunoglobulin heavy-chain matrix-associating regions are bound by Bright:
a B cell-specific trans-activator that describes a new DNA-binding protein
family. Genes Dev 9: 3067–82.
12. Forrester WC, van Genderen C, Jenuwein T, Grosschedl R (1994) Dependence
of enhancer-mediated transcription of the immunoglobulin mu gene on nuclear
matrix attachment regions. Science 265: 1221–5.
13. Bell AC, Felsenfeld G (2000) Methylation of a CTCF-dependent
boundary controls imprinted expression of the Igf2 gene. Nature 405:
482–485.
14. Hark AT, Schoenherr CJ, Katz DJ, Ingram RS, Levorse JM, et al. (2000) CTCF
mediates methylation-sensitive enhancer-blocking activity at the H19/Igf2 locus.
Nature 405: 486–489.
15. Oancea AE, Berru M, Shulman MJ (1997) Expression of the (recombinant)
endogenous IgH locus requires the intronic matrix attachment regions. Mol Cell
Biol 17: 2658–2668.
16. Yu W, Ginjala V, Pant V, Chernukhin I, Whitehead J, et al. (2004) Poly(ADP-
ribosyl)ation regulates CTCF-dependent chromatin insulation. Nat Genet 36:
105–110.
Variegated Gene Expression
PLoS ONE | www.plosone.org 11 December 2006 | Issue 1 | e3317. Grosschedl R, Baltimore D (1985) Cell type specificity of immunoglobulin gene
expression is regulated by at least three DNA sequence elements. Cell 41: 885.
18. Kadesch T, Zervos P, Ruezinsky D (1986) Functional analysis of the murine IgH
enhancer: evidence for negative control of cell-type specificity. Nucl Acids Res
14: 8209–8221.
19. Scheuermann RH, Chen U (1989) A developmental-specific factor binds to
suppressor sites flanking the immunoglobuin heavy-chain enhancer. Genes Dev
3: 1255–1266.
20. Wasylyk C, Wasylyk B (1986) The immunoglobulin heavy-chain B-lymphocyte
enhancer efficiently stimulates transcription in non-lymphoid cells. EMBO J 5:
553–560.
21. Forrester WC, Fernandez LA, Grosschedl R (1999) Nuclear matrix attachment
regions antagonize methylation-dependent repression of long-range enhancer-
promoter interactions. Genes Dev 13: 3003–14.
22. Jenuwein T, Forrester WC, Qiu RG, Grosschedl R (1993) The immunoglobulin
mu enhancer core establishes local factor access in nuclear chromatin
independent of transcriptional stimulation. Genes Dev 7: 2016–32.
23. Dobreva G DJ, Grosschedl R (2003) SUMO modification of a novel MAR-
binding protein, SATB2, modulates immunoglobulin mu gene expression.
Genes Dev 17: 3048–3061.
24. Sakai E, Bottaro A, Davidson L, Sleckman BP, Alt FW (1999) Recombination
and transcription of the endogenous Ig heavy chain locus is effected by the Ig
heavy chain intronic enhancer core region in the absence of the matrix
attachment regions. Proc Natl Acad Sci USA 96: 1526–1531.
25. Sutter NB, Scalzo D, Fiering S, Groudine M, Martin DIK (2003) Chromatin
insulation by a transcriptional activator. Proc Natl Acad Sci U S A 100:
1105–1110.
26. Kraus WL, Lis JT (2003) PARP goes transcription. Cell 113: 677–683.
27. Grosschedl R, Marx M (1998) Stable propagation of the active transcriptional
state of an immunoglobulin mu gene requires continuous enhancer function.
Cell 55: 645–654.
28. Porton B, Zaller DM, Lieberson R, Eckhardt LA (1990) Immunoglobulin heavy
chain enhancer is required to maintain transfected gamma-2A gene expression
in a pre-B-cell line. Mol Cell Biol. 10: 1076–1083.
29. Carter D, Chakalova L, Osborne C, Dai Y, Fraser P (2002) Long range
chromatin regulatory interactions in vivo. Nat Genet 32: 623–636.
30. Tolhuis B, Palstra R, Splinter E, Grosveld F, deLaat W (2002) Looping and
interaction between hypersensitive sites in the active b-globin locus. Mol Cell 10:
1453–1465.
31. Palstra R, Tolhuis B, Splinter E, Nijmeijer R, Grosveld F, et al. (2003) The beta-
globin nuclear compartment in development and erythroid differentiation. Nat
Genet 35: 190–194.
32. Zhao H, Dean A (2004) An insulator blocks spreading of histone acetylation and
interferes with RNA polymerase transfer between an enhancer and gene.
Nucleic Acids Res 32: 4903–4914.
33. Wiersma EJ, Ronai D, Berru M, Tsui FW, Shulman MJ (1999) Role of the
intronic elements in the endogenous immunoglobulin heavy chain locus. Either
the matrix attachment regions or the core enhancer is sufficient to maintain
expression. J Biol Chem 274: 4858–62.
34. Skog S, Eliasson E, Eliasson E (1979) Correlation between cell size and position
within the division cycle in suspension cultures of Chang liver cells. Cell Tissue
Kinetcs 12: 501–511.
35. Lee J, Costlow N (1987) A molecular titration assay to measure transcript
prevalence levels. Methods Enzymol 152: 633–648.
36. Bertrand E, Pictet R, Grange T (1994) Can hammerhead ribozymes be efficient
tools to inactivate gene function? Nucleic Acids Res 22: 293–300.
Variegated Gene Expression
PLoS ONE | www.plosone.org 12 December 2006 | Issue 1 | e33